Cipla informs about unaudited financial results

26 Jul 2023 Evaluate

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Cipla has informed that the Board of Directors of the Company at its meeting held today 26th July 2023, has approved the Unaudited Financial Results (standalone and consolidated) for the quarter ended 30th June 2023. The company has enclosed as follows: Unaudited financial results (standalone and consolidated) as per Indian Accounting Standards for the quarter ended 30th June 2023 and Limited review report (standalone and consolidated) by Walker Chandiok & Co LLP, Statutory Auditor of the Company for the quarter ended 30th June 2023. The meeting of the Board of Directors of the Company commenced at 12.30 am (IST). The end time of the meeting will be separately intimated to the Stock Exchanges on conclusion. The above-mentioned documents will also be available on the Company’s website www.cipla.com in the Investor Section.

The above information is a part of company’s filings submitted to BSE. 

Cipla Share Price

1407.55 -1.85 (-0.13%)
29-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1521.95
Dr. Reddys Lab 6279.95
Cipla 1407.55
Zydus Lifesciences 963.50
Lupin 1640.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.